Form 8-K - Current report:
SEC Accession No. 0001079973-25-000781
Filing Date
2025-05-13
Accepted
2025-05-13 08:00:25
Documents
16
Period of Report
2025-05-12
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cdio_8k.htm   iXBRL 8-K 35301
2 CERTIFICATE OF AMENDMENT TO THE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORP ex3x1.htm EX-3.1 4695
3 PRESS RELEASE ex99x1.htm EX-99.1 8613
  Complete submission text file 0001079973-25-000781.txt   279283

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cdio-20250512.xsd EX-101.SCH 3859
5 XBRL DEFINITION FILE cdio-20250512_def.xml EX-101.DEF 26725
6 XBRL LABEL FILE cdio-20250512_lab.xml EX-101.LAB 36859
7 XBRL PRESENTATION FILE cdio-20250512_pre.xml EX-101.PRE 25349
18 EXTRACTED XBRL INSTANCE DOCUMENT cdio_8k_htm.xml XML 6110
Mailing Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645
Business Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645 855-226-9991
Cardio Diagnostics Holdings, Inc. (Filer) CIK: 0001870144 (see all company filings)

EIN.: 870925574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41097 | Film No.: 25937221
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)